Tema Neuroscience and Mental Health ETF Rating $22.91 +0.40 (+1.78%) As of 07/3/2025 03:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Neuroscience and Mental Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MNTL Aggregate RatingModerate Buy 2.84Holdings in MNTL have an aggregate rating of Moderate Buy based on 601 analyst ratings issued in the past year covering 39 companies (93.1% of the portfolio).MNTL Aggregate Price Target$22.91High Prediction$22.91Average Prediction$22.91Low Prediction$22.91Holdings in MNTL have an aggregate price target of $22.91 and a range of $22.91 to $22.91 covering 39 companies (93.1% of the portfolio).MNTL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Neuroscience and Mental Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 MNTL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.47%VRTXVertex Pharmaceuticals$454.64-0.5%4.7287 of 5 stars2.54$511.62 12.5%28Positive News7.69%REGNRegeneron Pharmaceuticals$545.00-0.5%4.9415 of 5 stars2.80$813.57 49.3%25Trending News5.98%ALNYAlnylam Pharmaceuticals$331.94+0.7%4.3159 of 5 stars2.79$340.00 2.4%245.17%ARGXargenex$543.32-0.3%4.3327 of 5 stars3.05$728.06 34.0%21Analyst Forecast5.06%TEVATeva Pharmaceutical Industries$17.054.2308 of 5 stars3.22$24.13 41.5%94.83%NBIXNeurocrine Biosciences$128.04-1.1%4.9183 of 5 stars2.86$162.00 26.5%224.40%LLYEli Lilly and Company$779.60+0.0%4.988 of 5 stars2.75$1,011.61 29.8%20Positive News4.16%CRNXCrinetics Pharmaceuticals$29.88+1.5%3.5721 of 5 stars2.90$71.75 140.2%103.30%SYKStryker$392.00+0.0%4.6417 of 5 stars2.79$427.30 9.0%19Positive News3.28%BIIBBiogen$132.63-0.4%4.9475 of 5 stars2.38$188.48 42.1%322.93%IONSIonis Pharmaceuticals$42.98-1.4%4.6089 of 5 stars2.78$58.25 35.5%18Analyst Upgrade2.73%CPRXCatalyst Pharmaceuticals$21.64+0.9%4.9228 of 5 stars3.25$32.83 51.7%8Positive News2.61%MDTMedtronic$88.50+0.2%4.8988 of 5 stars2.63$97.87 10.6%19Trending News2.45%AXSMAxsome Therapeutics$105.36+1.4%4.7166 of 5 stars3.06$172.33 63.6%16Trending NewsAnalyst ForecastAnalyst Revision2.28%ACADACADIA Pharmaceuticals$20.95-1.4%4.7016 of 5 stars2.71$27.88 33.1%172.24%DNLIDenali Therapeutics$14.70-1.4%4.5373 of 5 stars3.06$33.71 129.4%171.98%XENEXenon Pharmaceuticals$34.70+4.0%3.2015 of 5 stars3.00$54.82 58.0%121.83%DXCMDexCom$82.73-1.0%4.8996 of 5 stars2.95$98.50 19.1%22Positive News1.83%JAZZJazz Pharmaceuticals$109.45-0.4%4.9363 of 5 stars2.92$184.00 68.1%13Positive NewsInsider Trade1.81%ALKSAlkermes$28.75-0.9%4.9363 of 5 stars2.83$40.00 39.1%12Positive NewsAnalyst Revision1.72%RNAAvidity Biosciences$29.13-0.8%2.2497 of 5 stars3.06$65.59 125.2%171.60%SRRKScholar Rock$35.35-0.6%3.8848 of 5 stars3.14$42.67 20.7%71.58%PTCTPTC Therapeutics$48.77-0.8%4.3337 of 5 stars2.67$65.00 33.3%15Analyst Revision1.57%OPCHOption Care Health$30.07-3.1%4.3725 of 5 stars2.88$35.50 18.1%8Positive News1.55%PENPenumbra$250.54+0.3%4.7391 of 5 stars2.88$302.40 20.7%17Positive NewsInsider Trade1.04%DAWNDay One Biopharmaceuticals$6.80+1.0%1.7551 of 5 stars3.13$30.57 349.6%8Upcoming Earnings0.93%IMVTImmunovant$16.800.0%1.5647 of 5 stars2.90$38.33 128.1%100.83%TALKTalkspace$2.76+4.9%3.9448 of 5 stars3.00$4.50 63.0%7Positive News0.72%SRPTSarepta Therapeutics$18.22+0.1%4.7339 of 5 stars2.44$60.88 234.2%25Trending News0.68%DYNDyne Therapeutics$9.05+1.2%3.513 of 5 stars3.00$41.13 354.4%170.63%NTLAIntellia Therapeutics$10.72-0.1%4.652 of 5 stars2.65$33.37 211.4%20News Coverage0.59%BHVNBiohaven$14.63-0.9%3.434 of 5 stars3.07$58.46 299.6%150.57%ACHCAcadia Healthcare$23.90+3.1%4.8642 of 5 stars2.60$47.94 100.6%100.53%VYGRVoyager Therapeutics$3.28+2.5%3.6912 of 5 stars3.13$13.39 308.2%80.47%PRAXPraxis Precision Medicines$47.28+2.1%3.19 of 5 stars2.78$92.11 94.8%90.39%SLDBSolid Biosciences$4.98+2.2%3.4393 of 5 stars3.17$15.10 203.5%12Gap Up0.32%PRTAProthena$6.47+2.4%2.8044 of 5 stars2.33$31.50 386.9%90.17%RAPPRapport Therapeutics$12.04+2.0%1.3748 of 5 stars3.00$28.00 132.6%1Gap Up0.16%ARVNArvinas$7.89-0.1%3.1257 of 5 stars2.55$20.29 157.1%22 This page (NASDAQ:MNTL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
